{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:04:12Z","timestamp":1794661452268,"version":"4.9.1"},"reference-count":162,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008307","name":"Beckman Research Institute, City of Hope","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA202712"],"award-info":[{"award-number":["R01CA202712"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1053\/j.seminhematol.2023.11.004","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T11:29:36Z","timestamp":1701084576000},"page":"255-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"title":["Epidemiology and etiology of diffuse large B-cell lymphoma"],"prefix":"10.1053","volume":"60","author":[{"given":"Sophia S.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0001","first-page":"489","article-title":"Global patterns and trends in the incidence of non-Hodgkin lymphoma","volume":"30","author":"Miranda-Filho","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.004_bib0002","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3324\/haematol.2016.148809","article-title":"Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project","volume":"101","author":"Perry","year":"2016","journal-title":"Haematologica"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.004_bib0003","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0004","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011","volume":"90","author":"Al-Hamadani","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/10428194.2021.1975188","article-title":"Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020-2025","volume":"63","author":"Kanas","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"24","key":"10.1053\/j.seminhematol.2023.11.004_bib0006","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1182\/blood-2012-07-440073","article-title":"Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases","volume":"120","author":"Laurini","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0007","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4172\/2155-9554.1000473","article-title":"Epidemiological Analysis of Lymphoma Subtypes in a Reference Center in Jo\u00e3o Pessoa, Paraiba, Brazil","volume":"6","author":"Caminha","year":"2018","journal-title":"Int J Phys Med Rehabil"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0008","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bjh.13586","article-title":"Classification of non-Hodgkin lymphoma in South-eastern Europe: review of 632 cases from the international non-Hodgkin lymphoma classification project","volume":"171","author":"Dotlic","year":"2015","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.004_bib0009","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ajh.21824","article-title":"Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification","volume":"85","author":"Yoon","year":"2010","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","article-title":"Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification","volume":"138","author":"Sun","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"35","key":"10.1053\/j.seminhematol.2023.11.004_bib0011","doi-asserted-by":"crossref","first-page":"e12120","DOI":"10.1097\/MD.0000000000012120","article-title":"Epidemiologic characteristics of malignant lymphoma in Hubei, China: A single-center 5-year retrospective study","volume":"97","author":"Meng","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0012","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00277-015-2543-4","article-title":"Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project","volume":"95","author":"Perry","year":"2016","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.004_bib0013","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jfma.2016.11.006","article-title":"Lymphoma in Taiwan: Review of 1347 neoplasms from a single institution according to the 2016 Revision of the World Health Organization Classification","volume":"116","author":"Chuang","year":"2017","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0014","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1620\/tjem.224.151","article-title":"Clinicopathological features of malignant lymphoma in Japan: the Miyagi Study","volume":"224","author":"Miura","year":"2011","journal-title":"Tohoku J Exp Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","article-title":"The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities","volume":"50","year":"2000","journal-title":"Pathology International"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0016","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/bjh.13876","article-title":"Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases","volume":"172","author":"Perry","year":"2016","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.004_bib0017","first-page":"1262","article-title":"Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database","volume":"52","author":"Kim","year":"2020","journal-title":"Cancer Res Treat"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0018","first-page":"4213","article-title":"Histopathological Features of Lymphoma in Yogyakarta, Indonesia","volume":"17","author":"Dwianingsih","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0019","first-page":"1","article-title":"Non-Hodgkin Lymphoma in the Middle East Is Characterized by Low Incidence Rates With Advancing Age","volume":"5","author":"Yaqo","year":"2019","journal-title":"J Glob Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0020","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1186\/s12889-021-11840-3","article-title":"Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019","volume":"21","author":"Touma","year":"2021","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.004_bib0021","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/10428194.2014.939967","article-title":"Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification","volume":"56","author":"Boudjerra","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0022","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00277-009-0801-z","article-title":"Frequencies of non-Hodgkin's lymphoma subtypes in Kuwait: comparisons between different ethnic groups","volume":"89","author":"Ameen","year":"2010","journal-title":"Ann Hematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0023","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1080\/10428190410001697386","article-title":"Clinical characteristics and pathological classification of non-Hodgkin's lymphoma in Kuwait. Results of a collaborative study with the International Lymphoma Study Group (ILSG)","volume":"45","author":"Temmim","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0024","first-page":"609","article-title":"Non-Hodgkin lymphoma in Jordan. Types and patterns of 111 cases classified according to the WHO classification of hematological malignancies","volume":"25","author":"Almasri","year":"2004","journal-title":"Saudi Med J"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41043-021-00261-y","article-title":"Spectrum of common Hodgkin lymphoma and non-Hodgkin lymphomas subtypes in Zambia: a 3-year records review","volume":"40","author":"Polepole","year":"2021","journal-title":"J Health Popul Nutr"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0026","first-page":"2513","article-title":"Incidence Trend for Non-Hodgkin Lymphoma in the North Tunisian Population, 1998-2009","volume":"17","author":"Benhassine","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0027","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/bjh.13885","article-title":"Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project","volume":"172","author":"Perry","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030403","article-title":"Changing Incidence and Survival of Primary Central Nervous System Lymphoma in Australia: A 33-Year National Population-Based Study","volume":"13","author":"Farrall","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0029","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/ijc.28849","article-title":"Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006","volume":"135","author":"van Leeuwen","year":"2014","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2006-11-051672","article-title":"Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"110","author":"Morton","year":"2007","journal-title":"Blood"},{"issue":"20","key":"10.1053\/j.seminhematol.2023.11.004_bib0031","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1182\/blood-2010-06-289561","article-title":"InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions","volume":"116","author":"Turner","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0032","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/asheducation.V2009.1.523.0010523","article-title":"The 2008 WHO classification of lymphomas: implications for clinical practice and translational research","author":"Jaffe","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.004_bib0033","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1158\/1055-9965.EPI-05-0346","article-title":"Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples","volume":"14","author":"Goldin","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0034","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2005-01-0140","article-title":"Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database","volume":"106","author":"Altieri","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.2009.07721.x","article-title":"Highly increased familial risks for specific lymphoma subtypes","volume":"146","author":"Goldin","year":"2009","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.004_bib0036","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2006-06-031948","article-title":"Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"109","author":"Wang","year":"2007","journal-title":"Blood"},{"issue":"48","key":"10.1053\/j.seminhematol.2023.11.004_bib0037","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jncimonographs\/lgu010","article-title":"Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Cerhan","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0038","first-page":"217","article-title":"[Secondary non-Hodgkin's lymphomas]","volume":"85","author":"Cappelaere","year":"1998","journal-title":"Bull Cancer"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.004_bib0039","first-page":"908","article-title":"Secondary non-Hodgkin's lymphoma after treatment for childhood cancer","volume":"5","author":"Eguiguren","year":"1991","journal-title":"Leukemia"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.004_bib0040","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3390\/cancers13112607","article-title":"Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies","volume":"13","author":"Zahnreich","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-017-0043-6","article-title":"Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma","volume":"8","author":"Tanba","year":"2018","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0042","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13578-022-00763-0","article-title":"Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders\/diseases","volume":"12","author":"Yu","year":"2022","journal-title":"Cell Biosci"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.004_bib0043","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ng.3105","article-title":"Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma","volume":"46","author":"Cerhan","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0044","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/hmg\/ddz228","article-title":"Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways","volume":"29","author":"Kleinstern","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0045","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/ejh.12513","article-title":"Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations","volume":"95","author":"Bassig","year":"2015","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0046","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/leu.2010.17","article-title":"Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma","volume":"24","author":"Abdou","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.004_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001378","article-title":"GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma","volume":"7","author":"Smedby","year":"2011","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0048","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/joim.12911","article-title":"The role of HLA variation in lymphoma aetiology and survival","volume":"286","author":"Zhong","year":"2019","journal-title":"J Intern Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.004_bib0049","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41375-022-01711-0","article-title":"Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes","volume":"36","author":"Berndt","year":"2022","journal-title":"Leukemia"},{"issue":"23","key":"10.1053\/j.seminhematol.2023.11.004_bib0050","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1182\/blood-2012-05-427989","article-title":"PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium","volume":"120","author":"Nieters","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0051","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","article-title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.004_bib0052","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ng.2666","article-title":"Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population","volume":"45","author":"Tan","year":"2013","journal-title":"Nat Genet"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.004_bib0053","doi-asserted-by":"crossref","first-page":"djv279","DOI":"10.1093\/jnci\/djv279","article-title":"Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types","volume":"107","author":"Sampson","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.004_bib0054","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"issue":"2B","key":"10.1053\/j.seminhematol.2023.11.004_bib0055","first-page":"1263","article-title":"Development of cancer in patients with primary immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.004_bib0056","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2010.02.005","article-title":"Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID)","volume":"9","author":"Schuetz","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0057","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2008.03.009","article-title":"Immunodeficiency-associated lymphomas","volume":"22","author":"Tran","year":"2008","journal-title":"Blood Rev"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0058","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbmt.2016.01.027","article-title":"Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study","volume":"22","author":"Vajdic","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.004_bib0059","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2012.140","article-title":"Cancer risk after organ transplantation","volume":"307","author":"Vajdic","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.004_bib0060","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ijc.24439","article-title":"Cancer incidence and risk factors after solid organ transplantation","volume":"125","author":"Vajdic","year":"2009","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0061","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1055-9965.EPI-09-1220","article-title":"Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients","volume":"19","author":"Quinlan","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.004_bib0062","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ajh.23726","article-title":"Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States","volume":"89","author":"Gibson","year":"2014","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0063","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.2013.294","article-title":"Risk of lymphoma subtypes after solid organ transplantation in the United States","volume":"109","author":"Clarke","year":"2013","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0064","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2009-02-202507","article-title":"Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation","volume":"114","author":"van Leeuwen","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan","year":"2011","journal-title":"Am J Hematol"},{"issue":"17","key":"10.1053\/j.seminhematol.2023.11.004_bib0066","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.004_bib0067","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0068","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson","year":"2009","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.004_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158360","article-title":"Origin of B-Cell Neoplasms in Autoimmune Disease","volume":"11","author":"Hemminki","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.004_bib0070","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0071","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multi-centre cohort study","volume":"42","author":"Bernatsky","year":"2013","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-Hodgkin lymphoma in primary Sjogren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.004_bib0073","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1016\/j.cgh.2023.04.001","article-title":"Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study","volume":"21","author":"Ol\u00e9n","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0074","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8631061","article-title":"Autoimmune\/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?","volume":"2016","author":"Yadlapati","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0075","first-page":"062","article-title":"Autoimmunity and Lymphoma: A Brief Review","volume":"4","author":"Miller","year":"2018","journal-title":"J Rheum Dis Treat"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0076","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.2005.044784","article-title":"Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis","volume":"65","author":"Franklin","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.004_bib0077","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0078","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/annrheumdis-2016-209389","article-title":"Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis","volume":"76","author":"Mercer","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0079","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.12624","article-title":"Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-alpha therapy in inflammatory bowel disease","volume":"39","author":"Williams","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X","article-title":"Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS\/Cancer Study Group","volume":"73","author":"Cote","year":"1997","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0081","first-page":"70","article-title":"AIDS-related malignancies: revisited","volume":"29","author":"Caceres","year":"2010","journal-title":"P R Health Sci J"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.004_bib0082","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.3390\/cancers15123191","article-title":"Diffuse Large B-Cell Lymphoma in the HIV Setting","volume":"15","author":"Huguet","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0083","first-page":"31","article-title":"HIV\/AIDS Associated Lymphoma: Review","volume":"12","author":"Berhan","year":"2022","journal-title":"Blood Lymphat Cancer"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0084","unstructured":"Kaplan LD, Ai W. HIV-related lymphomas: Epidemiology, risk factors, and pathobiology. 2023. Available from: https:\/\/www.uptodate.com\/contents\/hiv-related-lymphomas-epidemiology-risk-factors-and-pathobiology."},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/1055-9965.EPI-06-1056","article-title":"Infectious agents as causes of non-Hodgkin lymphoma","volume":"16","author":"Engels","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.004_bib0086","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study","volume":"4","author":"Hernandez-Ramirez","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0087","series-title":"Report on Carcinogens Monograph on Human Immunodeficiency Virus Type 1: RoC Monograph 08","year":"2016"},{"issue":"18","key":"10.1053\/j.seminhematol.2023.11.004_bib0088","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.004_bib0089","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi's sarcoma and its associated herpesvirus","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0090","unstructured":"National Toxicology Program. Report on Carcinogens Monograph on Kaposi Sarcoma-Associated Herpesvirus: RoC Monograph 10. Research Triangle Park (NC): National Toxicology Program; 2016 Aug. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK580448\/ 10.22427\/ROC-MGRAPH-10"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0091","unstructured":"Report on Carcinogens Monograph on Epstein-Barr Virus: RoC Monograph 07. RoC Monograph Series. Research Triangle Park (NC)2016."},{"issue":"Pt 1","key":"10.1053\/j.seminhematol.2023.11.004_bib0092","first-page":"315","article-title":"The Role of EBV in the Pathogenesis of Diffuse Large B Cell Lymphoma","volume":"390","author":"Healy","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"17","key":"10.1053\/j.seminhematol.2023.11.004_bib0093","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/archinte.163.17.1997","article-title":"Posttransplantation lymphoproliferative disorders","volume":"163","author":"Andreone","year":"2003","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0094","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0889-8588(03)00048-0","article-title":"Epidemiology of AIDS-related malignancies an international perspective","volume":"17","author":"Mbulaiteye","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J Hepatol"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.004_bib0096","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156384","article-title":"In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas","volume":"11","author":"Canioni","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0097","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/annonc\/mdx635","article-title":"From hepatitis C virus infection to B-cell lymphoma","volume":"29","author":"Couronne","year":"2018","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.004_bib0098","doi-asserted-by":"crossref","first-page":"e832","DOI":"10.1016\/j.clml.2021.06.014","article-title":"Risk of Non-Hodgkin's Lymphoma in HCV Patients in the United States Between 2013 and 2020: A Population-Based Study","volume":"21","author":"Alkrekshi","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0099","first-page":"134","article-title":"Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy","volume":"3","author":"Tasleem","year":"2015","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.004_bib0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"18","key":"10.1053\/j.seminhematol.2023.11.004_bib0101","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus","volume":"297","author":"Giordano","year":"2007","journal-title":"JAMA"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.004_bib0102","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.004_bib0103","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0104","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","article-title":"Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies","volume":"95","author":"Matsuo","year":"2004","journal-title":"Cancer Sci"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4254\/wjh.v8.i2.107","article-title":"Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options","volume":"8","author":"Pozzato","year":"2016","journal-title":"World J Hepatol"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.004_bib0106","doi-asserted-by":"crossref","first-page":"e14755","DOI":"10.1097\/MD.0000000000014755","article-title":"Hepatitis C virus infection is a risk factor for non-Hodgkin lymphoma: A MOOSE-compliant meta-analysis","volume":"98","author":"Zhu","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.004_bib0107","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/cncr.30559","article-title":"Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study","volume":"123","author":"Mahale","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.004_bib0108","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/ijc.29845","article-title":"Prevalence and association of hepatitis C virus infection with different types of lymphoma","volume":"138","author":"Iqbal","year":"2016","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0109","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1445-5994.2009.02060.x","article-title":"Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis","volume":"40","author":"Nath","year":"2010","journal-title":"Intern Med J"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0110","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.leukres.2013.06.007","article-title":"Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies","volume":"37","author":"Dalia","year":"2013","journal-title":"Leuk Res"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.004_bib0111","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12032-014-0084-7","article-title":"Association between infection of hepatitis B virus and onset risk of B-cell non-Hodgkin's lymphoma: a systematic review and a meta-analysis","volume":"31","author":"Yi","year":"2014","journal-title":"Med Oncol"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.004_bib0112","first-page":"22167","article-title":"Association of risk of non-Hodgkin's lymphoma with hepatitis B virus infection: a meta-analysis","volume":"8","author":"Qi","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0113","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1470-2045(10)70167-4","article-title":"Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study","volume":"11","author":"Engels","year":"2010","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.004_bib0114","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.canep.2015.06.002","article-title":"Hepatitis B and C virus infection and risk of lymphoid malignancies: A population-based cohort study (JPHC Study)","volume":"39","author":"Abe","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.004_bib0115","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/jvh.12892","article-title":"Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies","volume":"25","author":"Li","year":"2018","journal-title":"J Viral Hepat"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.004_bib0116","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.3324\/haematol.2016.144840","article-title":"Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B","volume":"101","author":"Kleinstern","year":"2016","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0117","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13027-016-0073-x","article-title":"Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy","volume":"11","author":"Taborelli","year":"2016","journal-title":"Infect Agent Cancer"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.004_bib0118","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/jvh.12391","article-title":"Risk of all-type cancer, hepatocellular carcinoma, non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus","volume":"22","author":"Andersen","year":"2015","journal-title":"J Viral Hepat"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0119","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/ijc.23344","article-title":"Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium","volume":"122","author":"Willett","year":"2008","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clml.2013.10.005","article-title":"Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies","volume":"14","author":"Castillo","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.004_bib0121","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1158\/1940-6207.CAPR-13-0132","article-title":"A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma","volume":"6","author":"Bertrand","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0122","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/1055-9965.EPI-07-0716","article-title":"Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort","volume":"17","author":"Maskarinec","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.004_bib0123","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/aje\/kwq085","article-title":"Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial","volume":"171","author":"Troy","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0124","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/aje\/kwp123","article-title":"Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study","volume":"170","author":"Pylypchuk","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.004_bib0125","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.18150","article-title":"Body size and risk of non-Hodgkin lymphoma by subtype: A pooled analysis from six prospective cohorts in the United States","volume":"197","author":"Teras","year":"2022","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0126","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/oem.2005.022418","article-title":"Occupational trichloroethylene exposure and non-Hodgkin's lymphoma: a meta-analysis and review","volume":"63","author":"Mandel","year":"2006","journal-title":"Occup Environ Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.004_bib0127","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/oemed-2013-101551","article-title":"Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLymph [correction of IinterLlymph] analysis","volume":"70","author":"Cocco","year":"2013","journal-title":"Occup Environ Med"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0128","unstructured":"International Agency for Research on Cancer. Benzene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2018. Volume 120."},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.004_bib0129","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2542-5196(21)00149-2","article-title":"Benzene exposure and non-Hodgkin lymphoma: a systematic review and meta-analysis of human studies","volume":"5","author":"Rana","year":"2021","journal-title":"Lancet Planet Health"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0130","first-page":"84","article-title":"[Classification as carcinogenic for 2,3,7,8-tetrachlorodibenzo-para-dioxin: an eventful journey]","volume":"33","author":"Apostoli","year":"2011","journal-title":"G Ital Med Lav Ergon"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0131","series-title":"1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide)","first-page":"3","year":"2008"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0132","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0009-2797(01)00175-2","article-title":"1,3-Butadiene, isoprene and chloroprene: reviews by the IARC monographs programme, outstanding issues, and research priorities in epidemiology","volume":"135-136","author":"Rice","year":"2001","journal-title":"Chem Biol Interact"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0133","first-page":"9","article-title":"Polychlorinated Biphenyls and Polybrominated Biphenyls","volume":"107","year":"2016","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.004_bib0134","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/ijc.23005","article-title":"Organochlorines and risk of non-Hodgkin lymphoma","volume":"121","author":"Spinelli","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.004_bib0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/oem.2007.033548","article-title":"Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes","volume":"65","author":"Cocco","year":"2008","journal-title":"Occup Environ Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0136","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12940-017-0214-8","article-title":"Prediagnostic plasma concentrations of organochlorines and risk of B-cell non-Hodgkin lymphoma in envirogenomarkers: a nested case-control study","volume":"16","author":"Kelly","year":"2017","journal-title":"Environ Health"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0137","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.chemosphere.2019.06.193","article-title":"Serum levels of polychlorinated biphenyls and risk of non-Hodgkin lymphoma: A hospital-based case-control study","volume":"235","author":"Magoni","year":"2019","journal-title":"Chemosphere"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0138","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chemosphere.2017.05.053","article-title":"Do polychlorinated biphenyls cause cancer? A systematic review and meta-analysis of epidemiological studies on risk of cutaneous melanoma and non-Hodgkin lymphoma","volume":"183","author":"Zani","year":"2017","journal-title":"Chemosphere"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0139","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/CEJ.0000000000000463","article-title":"Occupational and environmental exposure to polychlorinated biphenyls and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis of epidemiology studies","volume":"28","author":"Catalani","year":"2019","journal-title":"Eur J Cancer Prev"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.004_bib0140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/oemed-2022-108371","article-title":"Herbicide use in farming and other jobs in relation to non-Hodgkin's lymphoma (NHL) risk","volume":"79","author":"De Roos","year":"2022","journal-title":"Occup Environ Med"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.004_bib0141","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/ijc.33740","article-title":"Occupational insecticide exposure and risk of non-Hodgkin lymphoma: A pooled case-control study from the InterLymph Consortium","volume":"149","author":"De Roos","year":"2021","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.004_bib0142","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.21873\/anticanres.14552","article-title":"Association Between Pesticide Use and Incidence of Diffuse Large B-Cell Lymphoma","volume":"40","author":"Altahan","year":"2020","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0143","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/ije\/dyz017","article-title":"Pesticide use and risk of non-Hodgkin lymphoid malignancies in agricultural cohorts from France, Norway and the USA: a pooled analysis from the AGRICOH consortium","volume":"48","author":"Leon","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0144","first-page":"63","article-title":"Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis","volume":"111","author":"Donato","year":"2020","journal-title":"Med Lav"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.004_bib0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1289\/ehp.1409294","article-title":"Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium","volume":"124","author":"t Mannetje","year":"2016","journal-title":"Environ Health Perspect"},{"issue":"16","key":"10.1053\/j.seminhematol.2023.11.004_bib0146","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1158\/0008-5472.CAN-08-4372","article-title":"Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis","volume":"69","author":"Vajdic","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.004_bib0147","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood-2011-02-336065","article-title":"Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study","volume":"118","author":"Chang","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.004_bib0148","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.23003","article-title":"Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium","volume":"122","author":"Kricker","year":"2008","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.004_bib0149","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ijc.21913","article-title":"Tobacco smoking, alcohol drinking and non-Hodgkin's lymphoma: A European multicenter case-control study (Epilymph)","volume":"119","author":"Besson","year":"2006","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.004_bib0150","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/aje\/kwq309","article-title":"Alcohol consumption over time and risk of lymphoid malignancies in the California Teachers Study cohort","volume":"172","author":"Chang","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"48","key":"10.1053\/j.seminhematol.2023.11.004_bib0151","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Morton","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.004_bib0152","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1470-2045(05)70214-X","article-title":"Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis","volume":"6","author":"Morton","year":"2005","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.004_bib0153","first-page":"889","article-title":"Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis","volume":"30","author":"Cerhan","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.004_bib0154","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/aje\/kwn058","article-title":"Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma","volume":"167","author":"Zhang","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.004_bib0155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2023.11.004_bib0156","first-page":"134","article-title":"Cell of Origin (COO) Association with High Body Mass Index (BMI) and Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)","author":"Maignan","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.004_bib0157","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/aje\/kwu290","article-title":"Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci","volume":"181","author":"Wang","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.004_bib0158","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/1055-9965.EPI-21-0875","article-title":"B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS","volume":"31","author":"Wang","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.004_bib0159","doi-asserted-by":"crossref","first-page":"e26949","DOI":"10.1371\/journal.pone.0026949","article-title":"Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.004_bib0160","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1158\/0008-5472.CAN-06-4752","article-title":"Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res"},{"issue":"14","key":"10.1053\/j.seminhematol.2023.11.004_bib0161","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-17-2900","article-title":"HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.004_bib0162","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3324\/haematol.2022.281724","article-title":"Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm","volume":"108","author":"Liu","year":"2023","journal-title":"Haematologica"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:29:05Z","timestamp":1758522545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196323000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":162,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0037196323000914"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.11.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and etiology of diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}